|Bid||1,400.03 x 200|
|Ask||0.00 x 5000|
|Day's Range||1,400.03 - 1,400.03|
|52 Week Range||1,290.00 - 1,850.00|
|PE Ratio (TTM)||291.98|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Walgreens Boots Alliance’s (WBA) fiscal 3Q17 earnings per share (or EPS) are expected to rise 10.2% YoY (year-over-year) to $1.30.
These three retailer stocks all are all undervalued and have lots of potential to raise their dividends for years to come.
BioDelivery Sciences International, Inc. (BDSI) announced an agreement with CVS/Caremark to extend access to its pain management product Belbuca and opioid dependence product Bunavail through 2020.